Eye Health News and Research

Latest Eye Health News and Research

ACGME task force presents draft standards that revise requirements for better supervision, duty hours

The Accreditation Council for Graduate Medical Education task force charged with reassessing resident training program standards today presented a comprehensive set of draft standards that revise requirements for supervision and duty hours to better match residents' levels of experience and emerging competencies, advancing both graduate medical education and quality patient care in the nation's teaching hospitals.

24 Jun 2010

Extract of French maritime pine tree bark reduces hay fever symptoms

An estimated 60 million people in the U.S. are affected by allergic rhinitis, commonly known as hay fever, according to the American Academy of Allergy Asthma and Immunology. Hay fever is an allergic inflammation of the nasal airways that causes itching, swelling, mucus production, hives and rashes. A study published in the June 14, 2010 issue of Phytotherapy Research demonstrates Pycnogenol- (pic-noj-en-all), an antioxidant plant extract derived from the bark of the French maritime pine tree, substantially improves the symptoms of hay fever.

24 Jun 2010

Debiotech, STMicroelectronics to showcase novel insulin "Jewel Pump" at ADA Congress

Debiotech and STMicroelectronics today announced that they will publicly showcase their novel insulin "Jewel Pump" at the Debiotech stand at the American Diabetes Association 70th Scientific Sessions (June 25-29) in Orlando, Florida.

24 Jun 2010

FDA cancels Advisory Committee review of Lux Biosciences' voclosporin NDA

Isotechnika Pharma Inc. today announced that the U.S. Food and Drug Administration (FDA) has cancelled the Dermatology and Ophthalmology Drugs Advisory Committee review of partner, Lux Biosciences', New Drug Application (NDA) for voclosporin on June 28, 2010.

24 Jun 2010

Researchers study why the brain of newborn baby is particularly flexible

Science has long puzzled over why a baby's brain is particularly flexible and why it easily changes. Is it because babies have to learn a lot? A group of researchers from the Bernstein Network Computational Neuroscience, the Max Planck Institute for Dynamics and Self-Organization in G-ttingen, the Schiller University in Jena and Princeton University have now put forward a new explanation: Maybe it is because the brain still has to grow.

23 Jun 2010

Ensemble Discovery announces name change to Ensemble Therapeutics Corporation

Ensemble Discovery today announced that it will begin operating as Ensemble Therapeutics Corporation to reflect the Company's progress and emerging pipeline by applying its macrocycle drug platform to develop novel therapeutics. The new name, Ensemble Therapeutics, conveys the company's leadership and advancement in developing novel macrocycle drug compounds that are small molecules with expanded therapeutic properties of large molecule biological drugs.

22 Jun 2010

Tobii Technology announces launch of cost-effective eye tracking system

Tobii Technology, the global market leader in eye tracking, today announces the launch of Tobii Glasses™ a revolutionary, cost-effective eye tracking system. Tobii Glasses will help researchers in commercial, scientific, and government organisations to gain greater levels of insight into the preferences, reactions and personal experiences of people in a natural environment.

22 Jun 2010

QLT reports final 24-month results from Phase II RADICAL study in patients with wet AMD

QLT Inc. today announced final 24-month results from the Phase II RADICAL study (Reduced Fluence Visudyne Anti-VEGF-Dexamethasone In Combination for AMD Lesions) in patients with exudative (wet) age-related macular degeneration. The purpose of the study was to determine if Visudyne® combined with Lucentis® reduced retreatment rates compared with Lucentis monotherapy, while maintaining similar vision outcomes and an acceptable safety profile.

22 Jun 2010

OXiGENE reports encouraging data from ZYBRESTAT program at Glaucoma and Retinopathies 2010 conference

OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that the company presented an update on its ZYBRESTAT ophthalmology program, including encouraging preclinical data showing that the company's topical formulation achieved target retina/choroid concentrations with minimal systemic exposure.

22 Jun 2010

Tentative deal raises cigarette taxes in NY; Many Iowa hospitals close inpatient psychiatric units

Harvard Medical School, which has suffered financially due in part to a sharp decline in Harvard University's legendary endowment, has successfully negotiated a deal in which Boston's major teaching hospitals will contribute $36 million to the school over three years. The hospital money is a small portion of the medical school's $580 million annual budget, but it may represent a larger turning point in the unusual relationship between the country's top medical school and its prestigious hospital partners.

22 Jun 2010

Diabetes disease management program helps Medicare patients reduce cost of medical care: Study

Medicare patients with diabetes and cardiovascular disease can significantly reduce both the cost of their medical care and rates of hospitalization by participating in a telephone-based diabetes disease management program, a new study finds. The authors will present their results Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.

22 Jun 2010

Blind cyclists to travel from Toronto to Collingwood in support of the Foundation Fighting Blindness

On Saturday, June 19th, the vision impaired community will team up with cycling enthusiasts to embark on a 140 km journey for second annual Cycle for Sight, in support of the Foundation Fighting Blindness.

19 Jun 2010

National Cheng Kung University Hospital's Outpatient Building inaugurated

The Outpatient Building of National Cheng Kung University Hospital was officially inaugurated on June 12th to provide excellent medical service and to further ensure the health of people in Southern Taiwan.

18 Jun 2010

WTA report card: Many Canadian patients still face long waits for needed medical care

A Wait Time Alliance report card released today reveals troubling wait time hot spots in the five clinical areas deemed priorities by governments and more problems across a broader range of medical care.

18 Jun 2010

UMHHC expects to achieve 3.3% operating margin on revenues of $2.0 billion in fiscal year 2010

The Hospitals and Health Centers unit of the University of Michigan Health System will finish its fiscal year in strong financial shape, with a positive operating margin nearly twice the size predicted a year ago.

18 Jun 2010

Report: Proper contact lens replacement schedule compliance associated with better vision, comfort

A report published in the journal Optometry & Vision Science demonstrated that patients who replaced their silicone hydrogel contact lenses according to the manufacturer recommended replacement frequency experienced better comfort and vision at the end of the day than non-compliant patients. The analysis was part of a larger study sponsored by CIBA VISION, which was developed to investigate contact lens replacement schedule compliance.

18 Jun 2010

Study finds anxiety/panic disorder as most-disabling psychiatric disorder associated with TS

An assessment of patients with adult Tourette syndrome (TS) to identify clinical factors that contribute to psychosocial and occupational disabilities resulting from the vocal or motor tics that define TS found that anxiety/panic disorder may be the most disabling psychiatric condition associated with the disorder.

18 Jun 2010

WSJ: Study on eye medicine reveals possible savings for Medicare

The Wall Street Journal reports that Medicare could save $500 million a year by switching from one type of eye medicine to another, both made by Genentech, "according to a draft study by federal officials and a University of Miami eye doctor.

18 Jun 2010

First clinical trial results of XOMA 052 in patients with uveitis of Behcet's disease presented at EULAR 2010

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced positive results from an open-label pilot study of XOMA 052 in patients with uveitis of Behcet's disease who were suffering from vision-threatening exacerbations despite maximal doses of immunosuppressive medicines.

17 Jun 2010

Biological mechanism associated with remission during pregnancy

During pregnancy, many women experience remission of autoimmune diseases like multiple sclerosis and uveitis. Now, scientists have described a biological mechanism responsible for changes in the immune system that helps to explain the remission.

17 Jun 2010

Eye Health News and Research

Latest Eye Health News and Research

ACGME task force presents draft standards that revise requirements for better supervision, duty hours

Extract of French maritime pine tree bark reduces hay fever symptoms

Debiotech, STMicroelectronics to showcase novel insulin "Jewel Pump" at ADA Congress

FDA cancels Advisory Committee review of Lux Biosciences' voclosporin NDA

Researchers study why the brain of newborn baby is particularly flexible

Ensemble Discovery announces name change to Ensemble Therapeutics Corporation

Tobii Technology announces launch of cost-effective eye tracking system

QLT reports final 24-month results from Phase II RADICAL study in patients with wet AMD

OXiGENE reports encouraging data from ZYBRESTAT program at Glaucoma and Retinopathies 2010 conference

Tentative deal raises cigarette taxes in NY; Many Iowa hospitals close inpatient psychiatric units

Diabetes disease management program helps Medicare patients reduce cost of medical care: Study

Blind cyclists to travel from Toronto to Collingwood in support of the Foundation Fighting Blindness

National Cheng Kung University Hospital's Outpatient Building inaugurated

WTA report card: Many Canadian patients still face long waits for needed medical care

UMHHC expects to achieve 3.3% operating margin on revenues of $2.0 billion in fiscal year 2010

Report: Proper contact lens replacement schedule compliance associated with better vision, comfort

Study finds anxiety/panic disorder as most-disabling psychiatric disorder associated with TS

WSJ: Study on eye medicine reveals possible savings for Medicare

First clinical trial results of XOMA 052 in patients with uveitis of Behcet's disease presented at EULAR 2010

Biological mechanism associated with remission during pregnancy

Genetics & Genomics - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Eye Health News and Research

Latest Eye Health News and Research

Genetics & Genomics - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in